###begin article-title 0
Interleukin-10 Promoter Polymorphism is Associated with the Predisposition to the Development of IgA Nephropathy and Focal Segmental Glomerulosclerosis in Korea
###end article-title 0
###begin p 1
###xml 954 955 954 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 537 545 <span type="species:ncbi:9606">patients</span>
###xml 1196 1204 <span type="species:ncbi:9606">patients</span>
The roles of interleukin-10 (IL-10) have been emphasized in several models of glomerulonephritis (GN). Three biallelic polymorphisms within the IL-10 promoter region, at positions -1,082, -819, and -592 from the transcription initiation site, were shown to affect the level of IL-10 production. To investigate the effect of IL-10 promoter polymorphisms on the predisposition to development of GN in Korea, IL-10 promoter polymorphisms were assayed by polymerase chain reaction followed by restriction fragment length polymorphism in 108 patients with IgA nephropathy (IgAN), 49 focal segmental glomerulosclerosis (FSGS), and 100 healthy controls. In comparison with the control, the frequency of -1,082*G alleles were lower in IgAN and the frequencies of -592*C and -819*C were lower in FSGS, respectively. As for the haplotype, GCC haplotype was less frequent among IgAN than the control and ATA haplotype was more frequent among FSGS than the control (p<0.05). The frequency of intermediate producer genotypes (GCC/ACC and GCC/ATA) were lower among IgAN or FSGS than the control. Our findings suggested that IL-10 promoter polymorphism predisposed to the development of IgAN and FSGS in Korean patients.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 541 542 541 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 465 470 <span type="species:ncbi:9606">human</span>
Interleukin-10 (IL-10) is a multifunctional cytokine with diverse effects on the immune response. IL-10 limits inflammation and modulates immune response by inhibiting the production of various pro-inflammatory and Th1 cytokines and blocking the expression of MHC class II and co-stimulatory molecules on the surface of antigen presenting cells and promoting the development of regulatory T cells. On the other hand, IL-10 is a potent cofactor for proliferation of human B cells and affects the B cell differentiation and isotype switching (1).
###end p 3
###begin p 4
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 619 620 619 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 635 636 635 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1030 1032 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1128 1130 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1245 1247 1245 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1433 1435 1433 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 260 266 <span type="species:ncbi:10090">murine</span>
###xml 468 472 <span type="species:ncbi:10116">rats</span>
###xml 607 611 <span type="species:ncbi:10090">mice</span>
###xml 728 734 <span type="species:ncbi:10090">murine</span>
###xml 942 946 <span type="species:ncbi:10116">rats</span>
###xml 1009 1012 <span type="species:ncbi:10116">rat</span>
###xml 1122 1126 <span type="species:ncbi:10090">mice</span>
###xml 1136 1141 <span type="species:ncbi:9606">human</span>
###xml 1402 1410 <span type="species:ncbi:9606">patients</span>
The role of IL-10 in glomerulonephritides (GNs) has been investigated in several studies with conflicting results. The administration of IL-10 (2), endogenous IL-10 (3), or IL-10 gene transfer (4, 5) diminished Th1 response and attenuated glomerular injury in murine crescentic GN initiated by a planted antigen. IL-10 administration also inhibited passive anti-glomerular basement membrane (GBM) GN (6) and suppressed mesangial cell proliferation in anti-Thy 1 GN in rats (7). More recently, adenovirus mediated IL-10 transfer had effects on prevention of the development of glomerulosclerosis in FGS/Kist mice model (8). Yin et al. (9) reported IL-10 gene deficiency evoked more severe lupus nephritis and higher mortality in murine lupus model. But in other experiments, IL-10 administration induced mesangial cell proliferation with transient reduction of creatinine clearance (10) and had no protective effects on passive anti-GBM GN in rats (11). Moreover, IL-10 up-regulated MHC class II expression by rat mesangial cells (12) and anti-IL-10 antibodies administration diminished the severity of GN in "lupus-prone" mice (13). In human GN, increase in tubulointerstitial expression of IL-10 was accompanied by nephrotic-range proteinuria (14). We also observed that the increased intrarenal expression of IL-10 was associated with tubular atrophy and interstitial fibrosis in renal biopsies from patients with IgA nephropathy (15).
###end p 4
###begin p 5
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
The gene encoding IL-10 has been mapped to chromosome 1q and several polymorphic sites within the promoter region have recently been described (16). Three biallelic polymorphisms within the IL-10 promoter region, at positions -1,082, -819, and -592 from the transcription initiation site, have also been identified and one of these polymorphisms, at position -1,082 from the transcription initiation site, was shown to affect the in vitro IL-10 protein production in peripheral blood cells from healthy individuals (17).
###end p 5
###begin p 6
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 880 882 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 986 988 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 386 394 <span type="species:ncbi:9606">patients</span>
###xml 533 541 <span type="species:ncbi:9606">patients</span>
###xml 1424 1432 <span type="species:ncbi:9606">patients</span>
Based on the aforementioned biological effects of IL-10 and its role in GN, inter-individual differences in the levels of IL-10 production resulting from promoter polymorphism could influence the individual predisposition to several autoimmune diseases, including glomerulonephritides. Increased frequency of the GA/AA genotypes at position -1,082 of the IL-10 promoter was reported in patients with several autoimmune diseases (18, 19). In fact, IL-10 promoter polymorphism was associated with renal involvement in southern Chinese patients with systemic lupus erythematosus (20). Low IL-10 producer genotype was more prevalent in Caucasian kidney transplant recipients than in the control population (21). We also observed a lower frequency of G allele at position -1,082, denoting high IL-10 producer, in Korean kidney transplant recipients compared with the healthy controls (22). Glomerulonephritis is the most common cause of renal failure in Korean kidney transplant recipients (23). In addition IgA nephropathy and focal segmental glomerulosclerosis is two most common glomerulonephritis leading to end stage renal failure in Korea. It is therefore possible that IL-10 promoter polymorphisms may be responsible for, at least in part, a portion of the genetic predisposition to glomerulonephritides. The present study was undertaken to investigate the role of these 3 biallelic IL-10 promoter polymorphisms in Korean patients with IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS) which were common GNs leading to the end stage renal disease and considered to have different pathogenetic mechanism apart from each other.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and control subject
###end title 8
###begin p 9
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 176 184 <span type="species:ncbi:9606">patients</span>
###xml 218 226 <span type="species:ncbi:9606">patients</span>
###xml 439 447 <span type="species:ncbi:9606">Patients</span>
Patients were recruited from the Department of Internal Medicine, Kangdong Sacred Heart Hospital, and Seoul National University Hospital in Seoul, Korea. One hundred and eight patients with primary IgAN and forty nine patients with primary FSGS who provided informed consent, were enrolled in this study. The diagnosis of IgAN and FSGS was based on the typical light, immunofluorescent, and electron microscopic changes on a renal biopsy. Patients with the evidences of systemic diseases such as diabetes, chronic liver disease, and systemic lupus erythematosus were excluded. One hundred randomly selected subjects who had no evidence of renal disease and were normotensive were also recruited from the Health Promotion Center of the same hospitals as controls. The Institutional Review Board of two institutions approved the research protocol used for this study.
###end p 9
###begin title 10
Extraction of genomic DNA and genotype determination
###end title 10
###begin p 11
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 439 440 431 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 500 503 488 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 549 552 537 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 699 700 687 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2036 2039 2020 2023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mae</italic>
###xml 2044 2047 2028 2031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mnl</italic>
###xml 2286 2294 <span type="species:ncbi:9606">patients</span>
Genomic DNA was extracted from the buffy coat using commercial DNA isolation kit (Qiagen, Germany). The 3 biallelic IL-10 promoter polymorphisms were detected by PCR amplification followed by restriction enzyme digestion basically as described previously (24). Briefly, the DNA fragment containing the position -592 was amplified in 50 microL reaction mixture containing 500 ng of template DNA, 0.5 microM of of each primer, 1.5 mM of MgCl2, 200 microM each of dGTP, dATP, dTTP and dCTP, 2.5 unit of Taq polymerase (Promega, Medison WI, U.S.A.) and Taq polymerase buffer. Amplification of the fragment around -592 was performed under the same condition except that a final concentration of 2 mM MgCl2 was used. Amplification of fragment around -1,082 was performed using HotStarTaq kit (Qiagen, Germany), and Q-solution was included in the PCR reaction mixture. Primers used were as follows: for the amplification of -592 fragment, sense primer 5'gtgttcctaggtcacagtga, antisense primer 5'gtcatggtgagcactacctga 3'; for -819, sense primer 5'tcattctatgtgctggagatg 3', antisense primer 5'tgggggaagtgggtaagagt 3'; for -1,082, sense primer 5'ctcgctgcaacccaactggc 3', antisense primer 5'tcttacgcaacccaactggc 3'. PCR was performed using Perkin Elmer Cetus thermocycler under the following cycling parameters: denaturation at 94℃ for 2 min, followed by 35 cycles of denaturation at 94℃ for 30 sec; annealing at 60℃ for 45 sec; and extension at 72℃ for 1 min. This was followed by final extension at 72℃ for 10 min. For amplification of the -1,082, an initial activation step of 95℃ for 15 min preceded the cycling program. The two alleles at each polymorphic site was identified by incubating 15 microL aliquot of the PCR product with specific restriction enzyme, followed by electrophoresis on 3% agarose gels. Restriction enzyme RsaI cut the fragment at the position -592 when allele A was present, giving rise to 176 and 236 bp fragments. In the presence of allele C in -819 fragment, 125 and 84 bp fragments were generated by digestion with MaeIII. Mnl I cut -1082 fragment when allele G was present to generate 106 and 33 bp fragments. The results of this restriction fragment length polymorphism assay were confirmed by direct sequencing of the promoter region of the IL-10 gene in 10% of patients and controls (Macrogen Inc., Seoul, Korea).
###end p 11
###begin title 12
Statistical analysis
###end title 12
###begin p 13
###xml 272 273 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 143 151 <span type="species:ncbi:9606">patients</span>
All data were analyzed using the SPSS version 10.0. The chi-square test was used for detecting differences in the genotype distribution of the patients and controls. Odd ratio for individuals with a specific genotype to develop GN was estimated by Mantel-Haenszel test. A p-value that was less than 0.05 was considered to be statistically significant.
###end p 13
###begin title 14
RESULTS
###end title 14
###begin title 15
Allele frequencies of IL-10 promoter
###end title 15
###begin p 16
###xml 93 100 93 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Frequencies of the alleles of IL-10 promoter in our patients and controls were summarized in Table 1. For comparison, reported allele frequencies from southern Chinese (20) and U.K. white population (25) were also included. The polymorphisms at -592 and -819 bp were found to be in complete linkage disequilibrium. This meant that individuals with A allele at -592 bp also had T allele at -819 bp, whereas those with C allele at -592 bp also had C allele at -819 bp. The allele frequencies of our controls were very similar to those of Chinese population but markedly different from U.K. population. To point out, the frequency of G allele at position -1,082 was markedly lower among our controls than the U.K. population.
###end p 16
###begin p 17
###xml 111 112 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 236 237 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 9 17 <span type="species:ncbi:9606">patients</span>
For IgAN patients, the frequency of G allele at position -1,082 was even significantly lower than the control (p=0.006). For FSGS, the frequency of C allele at position -592 or at position -819 was significantly lower than the control (p=0.026).
###end p 17
###begin title 18
Haplotype frequencies of IL-10 promoter
###end title 18
###begin p 19
###xml 217 224 217 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 176 184 <span type="species:ncbi:9606">patients</span>
Three haplotypes were identified: GCC, ACC and ATA for the -1,082, -819 and -592 polymorphisms, respectively. The frequencies of the haplotypes of IL-10 promoter in IgAN, FSGS patients and controls were summarized in Table 2, 3.
###end p 19
###begin p 20
###xml 211 212 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 465 466 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
###xml 378 386 <span type="species:ncbi:9606">patients</span>
There was a statistically significant difference in the frequency of GCC haplotype between IgAN and control. That is, IgAN patients were less likely to carry GCC haplotype than normal controls (0.028 vs. 0.095, p=0.006). FSGS patients were less likely to carry GCC haplotype than controls, although this did not reach a statistical significance (0.031 vs. 0.095). Besides, FSGS patients had a higher frequency of ATA haplotype than normal control (0.755 vs. 0.620, p=0.026).
###end p 20
###begin title 21
Genotype frequencies of IL-10 promoter
###end title 21
###begin p 22
###xml 189 196 189 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
From our subjects, we observed five genotypic combinations of the three haplotypes: GCC/ACC, GCC/ATA, ACC/ACC, ACC/ATA and ATA/ATA. No GCC homozygous subjects were observed from our study (Table 4).
###end p 22
###begin p 23
###xml 201 202 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 245 246 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 584 585 584 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 628 629 628 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 3 11 <span type="species:ncbi:9606">patients</span>
No patients among the IgAN and FSGS group carried GCC/ACC genotype, while 8 (8%) among normal control group carried this genotype. This marked a statistical difference either between IgAN and control (p=0.002) or between FSGS and control group (p=0.049). There was no significant difference in the frequency of GCC/ATA genotype either between IgAN and control group or between FSGS and control group. However, as for the genotypic frequency of intermediate producer as a whole (i.e., GCC/ACC and GCC/ATA genotypes), there was a significant difference either between IgAN and control (p=0.005) or between FSGS and control group (p=0.048).
###end p 23
###begin title 24
DISCUSSION
###end title 24
###begin p 25
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 663 665 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 761 763 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 765 767 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 785 793 <span type="species:ncbi:9606">patients</span>
###xml 871 879 <span type="species:ncbi:9606">patients</span>
###xml 961 969 <span type="species:ncbi:9606">patients</span>
Three biallelic polymorphisms at positions -1,082(G/A), -819 (A/T) and -592 (A/C) of IL-10 promoter region are generally known to produce three haplotypes: GCC, ATA and ACC. Such allelic or haplotypic difference correlated with the difference in in vitro IL-10 production after various immunological stimuli. Even though not confirmed in recent study (26), Turner et al. reported that the presence of -1,082*A allele was associated with lower production of IL-10 by mitogen-stimulated peripheral blood leukocyte (17). In addition, the -592*A allele was associated with a reduced IL-10 production by peripheral blood mononuclear cell in the presence of IFN-gamma (27). Some authors classify IL-10 haplotypic variations into high, intermediate and low producers (28, 29). GCC homozygous patients were considered as high producers (i.e., GCC/GCC genotype), GCC heterozygous patients as intermediate producers (i.e., GCC/ACC and GCC/ATA genotypes) and GCC negative patients as low producers (i.e., ATA/ATA, ACC/ATA and ACC/ACC genotypes)
###end p 25
###begin p 26
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 416 424 <span type="species:ncbi:9606">patients</span>
###xml 588 596 <span type="species:ncbi:9606">patients</span>
In this study, we analyzed the polymorphic frequencies of the IL-10 promoter regions in Korean patients with IgAN and FSGS. We found that the distribution of alleles of IL-10 promoter in Korean healthy population is very similar to those in southern China population, but markedly different from Caucasian, which is consistent with the previous reports (17, 20, 24, 25). Characteristically, none of our controls and patients have the -1082*GG genotype or GCC/GCC genotype. This might mean that there was no one with "high IL-10 producing" phenotype among our subjects-either among the GN patients or among the healthy control.
###end p 26
###begin p 27
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 306 313 306 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
The frequencies of -1,082*G alleles, which were reported to be related with a higher IL-10 production (17, 28, 27), were lower in patients with IgAN than healthy controls. The frequencies of -819*C and -592*C, which are also known to represent a high producer, were also lower among FSGS than the control (Table 1).
###end p 27
###begin p 28
###xml 32 39 32 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 41 42 41 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 128 129 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 378 379 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 101 109 <span type="species:ncbi:9606">patients</span>
###xml 168 176 <span type="species:ncbi:9606">patients</span>
With respect to the haplotypes (Table 2, 3), there was a lower frequency of GCC haplotype among IgAN patients than the control (p=0.006, OR=0.27, CI [0.11-0.70]). FSGS patients were also less likely to carry the GCC haplotype, although not reached a statistical significance. ATA haplotype, which is known to represent a low producer, was more frequent among FSGS than control (p=0.026, OR=1.89, CI [1.09-3.25]).
###end p 28
###begin p 29
###xml 69 76 69 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
Such genetic difference is more pronounced in terms of the genotype (Table 4). None of our IgAN or FSGS group carried the GCC/ACC genotype, which marked a stark difference in comparison with the control group with 8% frequency of the GCC/ACC genotype. Such statistical difference still holds in terms of the intermediate producer group, GCC/ACC and GCC/ATA genotypes, as a whole. Collectively, these findings might mean that the lower level of IL-10 production resulting from IL-10 promoter polymorphism predisposes individuals to the development of IgAN and FSGS.
###end p 29
###begin p 30
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 154 162 <span type="species:ncbi:9606">patients</span>
Our findings are very similar to the study of Mok et al. (20) who demonstrated lower frequencies of -579*CC/-824*CC genotype and non-ATA haplotype in SLE patients with renal involvement. It was very interesting to note that IL-10 promoter polymorphisms predispose individuals to 3 different GNs, IgAN, FSGS, and lupus nephritis, which have an independent immunological pathogenesis. In addition, the frequency of -1,082*AA genotype was more prevalent in Caucacian kidney transplant recipient than in control group (21). In our 185 kidney transplant recipients, the frequencies of -592*CC/-819*CC and -1082*GA genotype were 9.2% and 5.9% respectively, which were lower than in controls (22). In this regard, it might be worthwhile to investigate the role of IL-10 promoter polymorphism in other nephropathies such as membranous GN, membranoproliferative GN and even diabetic nephropathy which are common causes of end stage renal disease.
###end p 30
###begin p 31
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 541 549 <span type="species:ncbi:9606">patients</span>
###xml 653 660 <span type="species:ncbi:9606">patient</span>
The biological effects of IL-10 and the role of IL-10 in GN is very complex and is beyond the scope of our discussion. From the results of the present study, it may be speculative that IL-10 limits inflammation and modulates injuries to kidney initiated by various different mechanisms. In this respect, IL-10 may play an important role in the process of progression common to both IgA nephropathy and FSGS. Recently IL-10 high producer genotype was reported to be associated with slower progression of IgA nephropathy and FSGS in Caucasian patients (30). Because our study was a cross-sectional study with a great variability in follow-up duration and patient characteristics affecting the progression of glomerulonephritis, we could not analysis the association of IL-10 gene polymorphism and progression of diseases. Well-designed prospective long-term study will be necessary to evaluate the role of IL-10 in the progression of various primary and secondary glomerular diseases having different mechanisms of pathogenesis such as IgA nephroapthy, FSGS, membranous nephropathy, lupus nephritis, and diabetic nephropathy.
###end p 31
###begin p 32
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
Finally, a cytokine works in the context of "networks of cytokines" i.e. many cytokines influence each other. The role of gene polymorphisms of various cytokines other than IL-10 in GN has been reported (31-33) and allelic distributions in cytokine gene polymorphisms varied according to the ethnic groups (25). In this context, it might be necessary to examine our observation as to the effect of IL-10 promoter gene polymorphism on the development of GN in different ethnic populations.
###end p 32
###begin p 33
###xml 35 60 35 60 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hallym Academy of Science</funding-source>
This research was supported by the Hallym Academy of Science, at Hallym University (2000), Korea.
###end p 33
###begin article-title 34
Interleukin-10 and the interleukin-10 receptor
###end article-title 34
###begin article-title 35
Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis
###end article-title 35
###begin article-title 36
Endogenous interleukin-10 regulates Th1 response that induce crescentic glomerulonephritis
###end article-title 36
###begin article-title 37
Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer
###end article-title 37
###begin article-title 38
###xml 132 136 <span type="species:ncbi:10116">rats</span>
Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar-Kyoto rats
###end article-title 38
###begin article-title 39
Interleukin-10 inhibits macrophage-induced glomerular injury
###end article-title 39
###begin article-title 40
Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis
###end article-title 40
###begin article-title 41
Suppression of glomerulosclerosis by adenovirus-mediated IL-10 expression in the kidney
###end article-title 41
###begin article-title 42
###xml 16 22 <span type="species:ncbi:10090">murine</span>
IL-10 regulates murine lupus
###end article-title 42
###begin article-title 43
Interleukin-10 is a mesangial cell growth factor in vitro and in vivo
###end article-title 43
###begin article-title 44
###xml 71 75 <span type="species:ncbi:10116">rats</span>
Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats
###end article-title 44
###begin article-title 45
Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo
###end article-title 45
###begin article-title 46
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice
###end article-title 46
###begin article-title 47
###xml 55 60 <span type="species:ncbi:9606">human</span>
In situ upregulation of IL-10 reflects the activity of human glomerulonephritides
###end article-title 47
###begin article-title 48
Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephroapathy
###end article-title 48
###begin article-title 49
###xml 15 20 <span type="species:ncbi:9606">human</span>
Mapping of the human IL-10 gene and further characterization of the 5'flanking sequence
###end article-title 49
###begin article-title 50
An investigation of poplymorphism in the interleukin-10 gene promoter
###end article-title 50
###begin article-title 51
Interleukin-10 (IL-10) genotypes in inflammatory bowel disease
###end article-title 51
###begin article-title 52
IL-10 gene promoter polymorphisms in rheumatoid arthritis
###end article-title 52
###begin article-title 53
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus
###end article-title 53
###begin article-title 54
Cytokine gene polymorphisms predict acute graft rejection following renal transplantation
###end article-title 54
###begin article-title 55
###xml 115 123 <span type="species:ncbi:9606">patients</span>
The impact of gene polymorphism of interleulin-10 and interferon-gamma on the clinical courses of renal transplant patients in Korea
###end article-title 55
###begin article-title 56
Single center study about post-transplant anemia (PTA) in Korean transplant recipients: prevalence and risk factors for PTA
###end article-title 56
###begin article-title 57
###xml 74 85 <span type="species:ncbi:11103">hepatitis C</span>
Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa
###end article-title 57
###begin article-title 58
Allele frequencies of polymorphisms of the tumor necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK
###end article-title 58
###begin article-title 59
A study of cytokine gene polymorphisms and protein secretion in renal transplantation
###end article-title 59
###begin article-title 60
Genetics of atopy and asthma: The rationale behind promoter-based candidate gene studies (IL-4 and IL-10)
###end article-title 60
###begin article-title 61
Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta1 and tumor necrosis factor-alpha genes: a technical report
###end article-title 61
###begin article-title 62
An investigation of polymorphism in the interleukin-10 gene promoter
###end article-title 62
###begin article-title 63
Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis
###end article-title 63
###begin article-title 64
Autoimmune renal disease and tumor necrosis factor beta gene polymorphism
###end article-title 64
###begin article-title 65
Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans
###end article-title 65
###begin article-title 66
Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy
###end article-title 66
###begin p 67
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Allele frequencies of the interleukin-10 promoter region among Korean patients and controls and southern Chinese and U.K. white population
###end p 67
###begin p 68
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 22 28 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 28 29 23 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p=0.026 vs. control, daggerp=0.006 vs. control.
###end p 68
###begin p 69
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Haplotype distribution of IL-10 promoter gene in IgAN patients and healthy control
###end p 69
###begin p 70
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p=0.006 vs. healthy controls.
###end p 70
###begin p 71
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Haplotype distribution of IL-10 promoter gene in FSGS patients and healthy control
###end p 71
###begin p 72
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p=0.026 vs. healthy controls.
###end p 72
###begin p 73
IL-10 genotype frequencies in healthy controls, IgAN and FSGS
###end p 73
###begin p 74
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 30 36 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 36 37 31 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 65 78 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 78 79 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 107 119 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#167;</sup>
###xml 119 120 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p=0.002 vs. healthy control, daggerp=0.049 vs. healthy control, double daggerp=0.005 vs. healthy control, section signp=0.048 vs. healthy control.
###end p 74

